|
In order to view this program you must log in. If you do not have an account, please register for one.
Viewing the webcast requires use of the free RealPlayer. 
If you are having problems viewing the program, please check out our technical support section.
|
| Credits | 1.00 |
| Release Date | 2/20/2009 |
| Termination Date | 2/20/2012 |
| Cost |
$25.00 to view the program and complete a post test for CME credit. To purchase this program please log in.
|
| Description | According to the National Institutes of Health, macular degeneration, or age-related macular degeneration is a leading cause of vision loss in Americans 60 and older. It is a disease that destroys a patient’s sharp, central vision. This activity is supported in part by educational grants from Merck and Astellas. |
| Accreditation Statement | The Ohio State University Medical Center, Center for Continuing Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Ohio State University Medical Center designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
| Author | Susie Chang, MD and John Christoforidis, MD |
| Objectives | Upon completion of this educational activity, the participant will be able to: 1.) Recognize signs of Dry Form of Macular Degeneration. 2.) Discuss treatment options for wet age-related macular degeneration (AMD). 3.) Review the use of photodynamic therapy in the treatment of Wet Form Macular Degeneration. 4.) Review the safety of ranibizumab in the treatment of wet age-related macular degeneration. |
| Audience | This course is designed for physicians. |
| Estimated Time to Complete | 1 Hour |
